Findings from University of Michigan in the Area of Managed Care Reported (Leveraging Administrative Claims To Understand Disparities In Gender Minority Health: Contraceptive Use Patterns Among Transgender and Nonbinary People): Managed Care

2022 APR 29 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- A new study on Managed Care is now available. According to news reporting originating from Ann Arbor, Michigan, by NewsRx correspondents, research stated, “Transgender people face disparities in access to reproductive and sexual health services; however, differences in receipt of contraceptive services have not been quantified. We compare contraceptive patterns between cisgender women and trans masculine people in insurance claims databases.”

Financial support for this research came from Society of Family Planning Research Fund.

Our news editors obtained a quote from the research from the University of Michigan, “We analyzed 2014-2018 Truven MarketScan data, using diagnostic and procedural codes to identify sex assigned at birth, and existing coding methodology to identify transgender and nonbinary people. We compared contraceptive patterns between cisgender women and trans masculine people aged 15-49 in Medicaid and commercial databases. We identified 4700 people in the commercial and 1628 people in the Medicaid databases as trans masculine. Trans masculine people were prescribed fewer oral contraceptive pills (Medicaid: 17.44%, commercial: 16.62%) compared to cisgender women (Medicaid: 24.96%, commercial: 27.85%), less long-acting reversible contraception (LARC) use (Medicaid: 7.62%, commercial: 7.49% vs. Medicaid: 12.79%, commercial: 8.51%), had more hysterectomies (Medicaid: 5.77%, commercial: 8.45% vs. Medicaid: 2.15%, commercial: 2.48%), and less evidence of any contraception (Medicaid: 34.21%, commercial: 32.28% vs. Medicaid: 46.80%, commercial: 39.81%). Hysterectomies and LARC use varied by insurance type. We found significant differences in contraceptive patterns between trans masculine people and cisgender women. Data suggest potential differences in hysterectomy occurrences by trans masculine people, and long-acting reversible contraceptive use by cisgender women, in Medicaid versus commercial insurance cohorts.”

According to the news editors, the research concluded: “Appropriate counseling, insurance coverage, and removal of structural barriers are needed to ensure adequate access to contraception methods for people of all genders-regardless of whether they are being employed for contraception, menstrual management, or gender affirmation.”

This research has been peer-reviewed.

For more information on this research see: Leveraging Administrative Claims To Understand Disparities In Gender Minority Health: Contraceptive Use Patterns Among Transgender and Nonbinary People. LGBT Health, 2022. LGBT Health can be contacted at: Mary Ann Liebert, Inc, 140 Huguenot Street, 3RD Fl, New Rochelle, NY 10801, USA.

The news editors report that additional information may be obtained by contacting Halley P. Crissman, University of Michigan, Dept. of Obstetrics and Gynecology, Ann Arbor, MI, United States. Additional authors for this research include Daphna Stroumsa, Anca Tilea, Molly B. Moravek, Lisa H. Harris, Vanessa K. Dalton and Caleb Haley.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1089/lgbt.2021.0303. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.

(Our reports deliver fact-based news of research and discoveries from around the world.)